Search filters

List of works by A Musolino

A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes

scientific article published on 01 May 2005

A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

scientific article published on 01 November 2020

A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer

scientific article

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.

scientific article

Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient.

scientific article

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

scientific article published on 01 March 2019

BOLERO-3 results: pharmacological activity or pharmacokinetic effect?

scientific article published on 01 July 2014

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

scientific article

Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.

scientific article published on 8 September 2016

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

scientific article published on 02 October 2018

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

scientific article published on 13 July 2017

Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity

scientific article published on 01 April 2006

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

scientific article published on 07 August 2018

FCGR, Cetuximab, and Colorectal Cancer Survival-Letter.

scientific article published in October 2016

Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review

scientific article published on 02 January 2020

Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study

scientific article published on 14 May 2012

Hypertriglyceridaemia with bexarotene in cutaneous T cell lymphoma: the role of omega-3 fatty acids.

scientific article published on 4 February 2009

Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.

scientific article

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer.

scientific article published on 5 July 2016

Intracranial hematopoiesis in a patient with AIDS-related central nervous system lymphoma and severe pancytopenia

scientific article published on 01 May 2007

Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma

scientific article

Lung cancer in patients with chronic lymphocytic leukemia: does the HER-2 oncogene play a role?

scientific article published on 26 August 2005

Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review

scientific article published on 13 August 2019

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study

scientific article published on 22 August 2019

Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.

scientific article

My best choice after a round trip from illness

scientific article published on 23 August 2017

Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review.

scientific article published on 23 October 2017

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡

scientific article published on 01 December 2018

PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtype

scientific article published on 25 August 2020

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy

scientific article published on 10 February 2017

Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study

scientific article

Prognostic Role of Immunoglobulin G Fragment C Receptor Polymorphisms in Solid Tumors.

scientific article published on 28 September 2017

Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study

scientific article published on 23 November 2017

Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers

scientific article published on 7 December 2015

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer

scientific article

Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy.

scientific article

Salivary MicroRNA for Diagnosis of Cancer and Systemic Diseases: A Systematic Review

scientific article published on 30 January 2020

The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer.

scientific article published on 3 February 2013

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

scientific article published on 21 November 2019

p73 and p53 pathway in human breast cancers

scientific article published on 01 April 2007

Paulina is supported by:

About Paulina

Help